L'intérêt à découvert pour InMode donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de InMode. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

InMode (NASDAQ:INMD) Stock, Rapport sur les intérêts à découvert

InMode

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.

InMode Ltd

U.S. stocks advanced midday Tuesday, demonstrating resilience despite escalating geopolitical tensions and trade uncertainties between the <a href="https://www.benzinga.com/news/econ-s">world&#8217;s two largest economies.</a>
China responded to President Donald Trump&#8216;s 10% import tariff with targeted countermeasures, including restrictions on key mineral exports to the U.S. and tariffs on American energy products.
Beijing is raising tariffs by 10%-15% on select U.S. imports, including coal, liquefied natural gas, crude oil, agricultural machinery and vehicles. Additionally, China added PVH Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) and Illumina Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>) to its &#8220;Unreliable Entity List,&#8221; citing the need to &#8220;safeguard national sovereignty, security, and development interests,&#8221; and opened an antitrust investigation on Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>).
Market participants had anticipated a call between Trump and Chinese President Xi Jinping on Tuesday, but media reports indicated the conversation would not happen today.
The trade developments had an immediate impact on oil markets, with West Texas Intermediate crude futures plunging 3% overnight to as low as $70 per barrel. 
Yet, prices rebounded sharply Tuesday morning following reports that Trump is considering issuing a memorandum aimed at inflicting <a href="https://www.benzinga.com/economics/macro-economic-events/25/02/43469234/trump-prepares-maximum-pressure-on-iran-oil-jumps-above-73-energy-stocks-rally">maximum economic damage on Iran</a>, potentially leading to a sharp decline in Iranian oil production.
Energy stocks outperformed on the day, while utilities lagged. 
Among individual stocks, Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) rocketed 22% after posting strong earnings and a revenue beat. 
In the commodities market, gold added more than 1%, extending its all-time high, and silver jumped 2.2%. Meanwhile, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) declined 2% to $99,000.
<h1 class="wp-block-heading">Tuesday&#8217;s Performance In Major U.S. Indices, ETFs</h1>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day % chg</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,281.54</td>
<td>1.0%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,495.31</td>
<td>0.9%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>6,029.97</td>
<td>0.6%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>44,501.00</td>
<td>0.2%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:55 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020325&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)&nbsp;rose 0.5% to $600.53.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) inched 0.1% higher to $444.77.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;rose 0.9% to $522.81.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) rallied 1.1% to $226.80.</li>
<li>The&nbsp;Energy Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) outperformed, up 1.9%; the&nbsp;Utilities Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>) lagged, down 0.8%.</li>
</ul>
<h1 class="wp-block-heading">Tuesday&#8217;s Stock Movers</h1>
Stocks reacting to earnings report included: 
<ul>
<li>Pfizer Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>): down 1.53%</li>
<li>PepsiCo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>): down 4.43%</li>
<li>Merck &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>): down 10.49%</li>
<li>PayPal Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>): down 11.57%</li>
<li>Archer-Daniels-Midland Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADM#NYSE">ADM</a>): down 3.58%</li>
<li>KKR &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>): down 7.90%</li>
<li>Cummins Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMI#NYSE">CMI</a>): up 3.81%</li>
<li>Enterprise Products Partners L.P. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPD#NYSE">EPD</a>): down 0.99%</li>
<li>Marathon Petroleum Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPC#NYSE">MPC</a>): up 5.85%</li>
<li>Estee Lauder Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>): down 16.35%</li>
<li>Apollo Global Management Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>): down 2.78%</li>
<li>Fox Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXA#NASDAQ">FOXA</a>): up 4.00%</li>
<li>Ametek Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>): down 1.00%</li>
<li>Xylem Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYL#NYSE">XYL</a>): up 5.85%</li>
<li>Ferrari NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RACE#NYSE">RACE</a>): up 7.62%</li>
<li>Spotify Technology SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>): up 10.46%</li>
<li>Regeneron Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>): up 4.71%</li>
<li>Jacobs Solutions Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/J#NYSE">J</a>): down 2.72%</li>
<li>Aramark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARMK#NYSE">ARMK</a>): down 1.51%</li>
<li>Gartner Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IT#NYSE">IT</a>): up 0.77%</li>
<li>Centene Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>): down 3.41%</li>
<li>Atkore Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATKR#NYSE">ATKR</a>): down 20.50%</li>
<li>Berry Global Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BERY#NYSE">BERY</a>): up 4.15%</li>
<li>WEC Energy Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WEC#NYSE">WEC</a>): down 1.52%</li>
<li>Hubbell Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUBB#NYSE">HUBB</a>): down 0.55%</li>
<li>TransDigm Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDG#NYSE">TDG</a>): down 1.60%</li>
<li>Graphic Packaging Holding Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPK#NYSE">GPK</a>): down 1.76%</li>
<li>CNH Industrial NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNHI#NYSE">CNHI</a>): up 1.71%</li>
<li>Ingredion Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INGR#NYSE">INGR</a>): down 6.12%</li>
<li>ATI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>): up 7.02%</li>
<li>Ball Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BALL#NYSE">BALL</a>): down 8.03%</li>
<li>Lancaster Colony Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LANC#NASDAQ">LANC</a>): up 9.27%</li>
<li>Premier Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PINC#NASDAQ">PINC</a>): down 15.36%</li>
<li>MPLX LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPLX#NYSE">MPLX</a>): up 2.92%</li>
<li>Oaktree Specialty Lending Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCSL#NASDAQ">OCSL</a>): down 3.42%</li>
<li>PJT Partners Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PJT#NYSE">PJT</a>): up 12.77%</li>
<li>Energizer Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENR#NYSE">ENR</a>): down 4.45%</li>
<li>Silicon Laboratories Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLAB#NASDAQ">SLAB</a>): down 1.05%</li>
<li>Hamilton Lane Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLNE#NASDAQ">HLNE</a>): down 0.01%</li>
<li>Madison Square Garden Sports Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSGS#NYSE">MSGS</a>): down 3.74%</li>
<li>Pentair Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNR#NYSE">PNR</a>): down 1.89%</li>
<li>Amcor Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMCR#NYSE">AMCR</a>): up 3.87%</li>
<li>Inmode Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INMD#NASDAQ">INMD</a>): up 2.82%</li>
<li>Willis Towers Watson Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>): down 3.54%</li>
<li>Axalta Coating Systems Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXTA#NYSE">AXTA</a>): up 7.86%</li>
<li>Mesa Laboratories Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLAB#NASDAQ">MLAB</a>): up 10.48%</li>
</ul>
Major companies reporting their earnings after the close are Alphabet Inc., Amgen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>), Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), Mondelez International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDLZ#NASDAQ">MDLZ</a>), Chipotle Mexican Grill Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>), Electronic Arts Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EA#NASDAQ">EA</a>), Prudential Financial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRU#NYSE">PRU</a>), Simon Property Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPG#NYSE">SPG</a>), Atmos Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATO#NYSE">ATO</a>), Aspen Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZPN#NASDAQ">AZPN</a>), Carlisle Cos. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSL#NYSE">CSL</a>), Fair Isaac Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FICO#NYSE">FICO</a>), Jack Henry &amp; Associates Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JKHY#NASDAQ">JKHY</a>), Idex Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) and Enphase Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>).
Read Now: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43468887/robert-f-kennedy-nomination-advances-to-full-senate-vaccine-stocks-drop">Robert F. Kennedy&#8217;s Health Secretary Nomination Advances To Full Senate: Vaccine Stocks Drop</a></li>
</ul>
Photo: Marek Masik via Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Macro Economic Events

Commodities

Global

Econ #s

Economics

Markets

Tech

$BTC

AMCR

AMGN

ARMK

ATKR

AXTA

AZPN

BALL

BERY

CNHI

SPDR Dow Jones Industrial Average ETF Trust

ENPH

FICO

FOXA

GOOG

GOOGL

HLNE

HUBB

ILMN

INGR

INMD

JKHY

LANC

MDLZ

MLAB

MPLX

MSGS

OCSL

PINC

PLTR

PYPL

RACE

REGN

SLAB

SPOT

US Stocks Rise Despite China's Trade Fears, Palantir Defies Gravity, Gold Rallies Further: What's Driving Markets Tuesday?

Needham analyst Mike Matson maintains InMode (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INMD#NASDAQ">INMD</a>) from Hold to Hold.

News

Analyst Ratings

Needham Maintains Hold on InModeto Hold

On February 3rd, our Board of Directors approved another tax-efficient share repurchase program of up to 10% of our total shares outstanding, expected to be executed over the next three to six months. Together with our 2024 share repurchases, this represents approximately 27% of share capital to be bought within less than 15 months.

Earnings

Buybacks

InMode Board Approves New Share Buyback Program For Up To 10% Of Outstanding Shares, Bringing 15-Month Buybacks To 27% Of Share Capital

2025 Financial Outlook
Management provided an outlook for the full year of 2025 ending December 31, 2025. Based on our current estimates, management expects:
<ul>
<li>Revenues between $395 to $405 million</li>
<li>&#x2A;Non-GAAP gross margin between 80% and 82%</li>
<li>&#x2A;Non-GAAP income from operations to be between $130 million and $135 million</li>
<li>&#x2A;Non-GAAP earnings per diluted share between $1.95 to $1.99</li>
</ul>

Guidance

Health Care

General

InMode Expects 2025 Revenues Of $395M-$405M Compared To Consensus Of $411.452M, With Adjusted EPS Of $1.95-$1.99 Compared To Consensus Of $2.02

InMode (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INMD#NASDAQ">INMD</a>) reported quarterly earnings of $0.42 per share which missed the analyst consensus estimate of $0.52 by 19.23 percent. This is a 40.85 percent decrease over earnings of $0.71 per share from the same period last year. The company reported quarterly sales of $97.85 million which missed the analyst consensus estimate of $106.55 million by 8.16 percent. This is a 22.82 percent decrease over sales of $126.78 million the same period last year.

InMode Q4 2024 Adj EPS $0.42 Misses $0.52 Estimate, Sales $97.85M Miss $106.55M Estimate

ALGT

APAM

ATEN

AUDC

AVNW

AZEK

COLM

CRUS

CVRX

EGHT

ENVA

FLNG

GBDC

ICHR

IESC

INNV

INTA

JNPR

KLIC

KTCC

LARK

LUMN

MRCY

MTCH

MUFG

OSCR

Earnings Scheduled For February 4, 2025

Hedge Funds

InMode Shareholder DOMA Perpetual Sends Letter Sends To Board Saying It Believes Board Must Immediately Execute Tender Offer For 30% Of The Company

Barclays analyst Matt Miksic maintains InMode (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INMD#NASDAQ">INMD</a>) with a Overweight and lowers the price target from $27 to $26.

Price Target

Barclays Maintains Overweight on InMode, Lowers Price Target to $26

WIIM

InMode shares are trading lower after the company issued Q4 revenue guidance below estimates and cut its FY24 and FY25 revenue guidance

InMode Expects Full-Year 2025 Revenue Of $395M - $405M, Est $421.368M

InMode Cuts FY24 Revenue Outlook From $410M - $420M To $394M - $394.5M, Est $411.188M

Management believes that preliminary results reflect stronger-than-expected headwinds in the aesthetics industry, further intensified by broader macroeconomic challenges.&nbsp;

InMode Expects Q4 Revenue Of $97.0M-$97.5M (Est $114.22M); Preliminary Results Reflect Stronger-than-Expected Headwinds In Aesthetics Industry

We like to look at places that the rest of the world, especially Wall Street and all the instant experts on the Internet, are ignoring.
Right now, all eyes are on, and have been on, US markets.
The United States has gotten everything right over the past decade, and the rest of the planet has been, as Bogart used to lament, at least two drinks behind.
We recovered from both the Great Financial Crisis and COVID quicker, flooded the zone with cash from every imaginable source, and inflated lovely asset bubbles while Europe and Asia staggered along.
US markets went to the moon, while even the best foreign markets never broke free of gravity.
At the end of the GFC, US stocks were 41% of the global market, which has swelled to about 65% today.
The last time US stocks were this dominant, Lyndon Johnson was still in the White House, college kids were going &#8220;Clean for Gene&#8221; and Bobby Kennedy Sr. was mulling over a run for President.
William McChesney Martin Jr. was the Fed Chair, Gerry Tsai was the hottest fund manager, and Jamie Dimon turned 12 years old.
US stocks were all the rage and then delivered a whopping return of zero for the next 14 years, with several disastrous bear markets along the way.
The S&amp;P 500 (Ticker: SPY) lost about 4.5% a year on average.
International stocks outperformed US stocks by a dangerous margin, with a revitalized Japan leading the way higher.
That does not mean that it will happen again, right?
After all, we just elected a pro-business, low-tax President and interest rates will be moving lower.
Not only can it happen again, I would suggest it is likely to happen again.
I might also suggest you Google (Ticker: GOOGL) &#8220;Richard Nixon,&#8221; &#8220;Arthur Burns,&#8221; and &#8220;The Nifty Fifty&#8221; when you can.
The world loves the US stock market right now, and no one is considering Europe or Asia as investment opportunities.
That means that it is Under the Radar, and we are interested.
While economic growth outside the United States has been somewhat sluggish, this does not mean there has been zero growth.
Several companies have shown outstanding growth, and we want to start our international expedition in search of excess profits there.
My favorite growth measures are not earnings-related. It has long been my theory—and it holds up to rigorous testing—that the best growth measures are revenues and book value growth.
If revenues are high and cash has been reinvested in the business in a manner that grows the company&#8217;s net worth, that is sustainable growth.
A good accountant can make earnings appear to be whatever they desire, but the amount of stuff sold and the bottom-line net worth of the business are much harder to twist.
The income statement is the story, but the balance sheet is the finale.
Turkcell Iletisim Hizmetleri A.S. ADR (Ticker: TKC) is a great example of a sustainable growth company that is way off anyone&#8217;s radar screen. Turkey is hardly a hot topic of conversation around the water coolers of Wall Street or any other street in the United States.
Turkcell is a digital communication company operating in Belarus and Northern Cyprus. The company offers cell service, data, TV, and digital services over its network in its core markets.
It is growing like crazy, with revenues increasing by 42 percent annually over the past five years and the company&#8217;s value rising even faster, with book value rising by more than 60 percent a year.
The company is still in a hyper-growth phase with no signs of stopping.
The beauty of Turkcell lies in its ability to evolve. This is not your average telecom giant stuck in a rut of traditional services. Turkcell has embraced digital transformation with open arms, rolling out fintech solutions, digital subscriptions, and even cloud services. Couple this with its early investments in 5G, and you have a business poised to capture a huge slice of the digital economy in Turkey and surrounding countries.
Despite the noise around Turkey&#8217;s economic challenges, Turkcell has delivered consistent revenue growth and maintained fair profit margins. It is a cash-generating machine, and management has not forgotten about shareholders, doling out reliable dividends year after year. Add to that a valuation that is downright cheap compared to global peers, and you have a stock that ticks all the right boxes.
The stock has been moving higher but trades at a very reasonable valuation of just 15 times trailing earnings. If they come close to hitting this year&#8217;s earnings estimate, the stock will be trading at a single-digit P/E.
Growing earnings and an expanding multiple can create a wildly profitable combination in Turkcell shares for investors willing to look outside the United States for opportunities.
It is not always easy to be beautiful.
In fact, sometimes, it requires the help of surgeons and a collection of medical devices.
Many of these devices are made by InMode (Ticker: INMD), an Israeli company that manufactures minimally invasive technologies and devices for aesthetic repair and touch-ups without surgery, scars, or lasers.
This Israeli-based medical device company has carved out a sweet spot in the aesthetics industry with its minimally invasive and non-invasive body contouring and skin-tightening solutions.
InMode has built a reputation for delivering products that providers and patients love, and the financials prove it. The company boasts outstanding margins and a fortress-like balance sheet with zero debt and a growing pile of cash. Management has shown they know how to run a tight ship and are committed to rewarding shareholders, evidenced by their share buyback program.
The aesthetics market is not slowing down anytime soon, with growing demand fueled by rising disposable incomes and a global shift toward non-invasive beauty treatments. InMode&#8217;s innovative product pipeline keeps it ahead of competitors, ensuring a steady stream of revenue growth.
Over the last five years, sales have grown at over 30% annually, and InMode&#8217;s net worth is growing at almost 60% a year.
At its current valuation, InMode is a steal. You are getting a high-growth, high-margin business that throws off cash and operates in a market with tailwinds for years to come.
U.S. investors are ignoring the rest of the world.
Europe, in particular, is out of favor.
The economy is a mess. The stock markets are moribund.
The only rational choice is to start shopping for high-growth bargains and undervalued asset conversion opportunities (more on this next week)

Opinion

Under the Radar: From Overlooked to Overperforming - Global Markets Await

Needham analyst Mike Matson reiterates InMode (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INMD#NASDAQ">INMD</a>) with a Hold.

Reiteration

Needham Reiterates Hold on InMode

InMode Cuts FY24 Revenue Outlook From $430M - $440M To $410M - $420M (Est $419.925M), Adj EPS Guidance Remains The Same As In Previous Guidance At $1.92 - $1.96 (Est $1.87)

InMode (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INMD#NASDAQ">INMD</a>) reported quarterly earnings of $0.70 per share which beat the analyst consensus estimate of $0.63 by 11.11 percent. This is a 14.75 percent increase over earnings of $0.61 per share from the same period last year. The company reported quarterly sales of $130.23 million which beat the analyst consensus estimate of $127.00 million by 2.54 percent. This is a 5.78 percent increase over sales of $123.11 million the same period last year.

Earnings Beats

InMode Q3 2024 Adj EPS $0.70 Beats $0.63 Estimate, Sales $130.23M Beat $127.00M Estimate

Legal

InMode Says It Is Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales Of Morpheus8 Radiofrequency Devices and Cartridge Accessories

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Loop Capital analyst Anthony Chukumba initiated coverage on Grocery Outlet Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GO#NASDAQ">GO</a>) with a Hold rating and announced a price target of $17. Grocery Outlet shares closed at $16.45 on Wednesday. <a href="https://www.benzinga.com/quote/GO/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Bernstein analyst Aaron Gal initiated coverage on Gilead Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) with an Outperform rating and announced a price target of $105. Gilead Sciences shares closed at $85.82 on Wednesday. <a href="https://www.benzinga.com/quote/GILD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stephens &amp; Co. analyst Jim Salera initiated coverage on First Watch Restaurant Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRG#NASDAQ">FWRG</a>) with a Overweight rating and announces Price Target of $20. First Watch Restaurant shares closed at $14.77 on Wednesday. <a href="https://www.benzinga.com/quote/FWRG/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>BTIG analyst Sam Eiber initiated coverage on InMode Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INMD#NASDAQ">INMD</a>) with a Buy rating and announced a price target of $25. InMode shares closed at $16.65 on Wednesday. <a href="https://www.benzinga.com/quote/INMD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>HC Wainwright &amp; Co. analyst Mitchell Kapoor initiated coverage on Alumis Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALMS#NASDAQ">ALMS</a>) with a Buy rating and announced a price target of $30. Alumis shares closed at $11.20 on Wednesday. <a href="https://www.benzinga.com/quote/ALMS/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying GILD stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="522" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/17090107/image-149-1024x522.png" alt="" class="wp-image-600656" style="width:638px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/17090107/image-149-1024x522.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/17090107/image-149-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/17090107/image-149-768x391.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/17090107/image-149.png 1317w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41377157/top-3-risk-off-stocks-which-could-rescue-your-portfolio-this-quarter">Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter</a></li>
</ul>

Initiation

Pre-Market Outlook

Trading Ideas

ALMS

FWRG

GILD

This Gilead Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

BTIG analyst Sam Eiber initiates coverage on InMode (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INMD#NASDAQ">INMD</a>) with a Buy rating and announces Price Target of $25.

BTIG Initiates Coverage On InMode with Buy Rating, Announces Price Target of $25

Barclays analyst Matt Miksic maintains InMode (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INMD#NASDAQ">INMD</a>) with a Overweight and lowers the price target from $29 to $27.

Barclays Maintains Overweight on InMode, Lowers Price Target to $27

DOMA Perpetual Capital Management, a significant stockholder of InMode (INMD), sent a letter to the Board of Directors of InMode urging the Board t...

DOMA Perpetual urges InMode to accelerate, increase its stock repurchase

InMode: A Clear Bargain With Unique Risks

InMode Q4 2024 Earnings Preview

Here's the major earnings before the open tomorrow

InMode Non-GAAP EPS of $0.42 misses by $0.08, revenue of $97.9M misses by $7.1M

Sees FY25 revenue $395M-$405M, consensus $407.76M. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial ...

InMode sees FY25 adjusted EPS $1.95-$1.99, consensus $1.95

"On February 3rd, our Board of Directors approved another tax-efficient share repurchase program of up to 10% of our total shares outstanding, expe...

InMode announces new share repurchase program

InMode ( ($INMD) ) has shared an update. On February 4, 2025, InMode Ltd. reported its financial results for the fourth quarter and full year of 20...

InMode Reports Decrease in 2024 Revenues, Announces New Share Repurchase Program

In a report released today, Michael Matson from Needham maintained a Hold rating on InMode (INMD – Research Report). The company's shares opened to...

InMode (INMD) Receives a Hold from Needham

In a report released today, Sam Eiber from BTIG reiterated a Buy rating on InMode (INMD – Research Report), with a price target of $25.00. The comp...

BTIG Remains a Buy on InMode (INMD)

BNPQF

DASTY

IFNNY

ISNPY

Press Releases

InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy

InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024

InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories

InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024)

InMode to Present at Upcoming Investor Conferences

InMode to Report Fourth Quarter & Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025,  Expects Q4 Revenue Between $97.0M-$97.5M

DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Immediately Execute Tender Offer followed by Share Buyback

InMode to Report Fourth Quarter & Full Year 2024 and Hold Conference Call on February 4, 2025, Earlier than Originally Announced

InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference

InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program

Comments

InMode

Intérêt court

InMode (NASDAQ:INMD) Stock, Rapport sur les intérêts à découvert

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL